Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfentanil for analgesia during burn dressing changes
ChiCTR2100049119Phase 4Not yet recruiting
- Sponsor
- Ruijin Hospital
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of alfentanil in burn injury (2 arms), sponsored by Ruijin Hospital. Primary endpoints: Visual analogue score and Verbal Rating Scale. Planned start Aug 2021; status: not yet recruiting.
02
Drugs
alfentanil
03
Conditions
burn injury
Beyond the preview
Go deeper on ChiCTR2100049119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049119.